207 related articles for article (PubMed ID: 27502935)
1. Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
Mathieu R; Korn SM; Bensalah K; Kramer G; Shariat SF
World J Urol; 2017 Apr; 35(4):567-577. PubMed ID: 27502935
[TBL] [Abstract][Full Text] [Related]
2. Role of radical prostatectomy in metastatic prostate cancer: A review.
Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
[TBL] [Abstract][Full Text] [Related]
4. [Cytoreductive, radical prostatectomy in metastatic prostate cancer].
Chaloupka M; Herlemann A; Spek A; Gratzke C; Stief C
Urologe A; 2017 Nov; 56(11):1430-1434. PubMed ID: 28983651
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive prostatectomy: what is the evidence? A systematic review.
Albisinni S; Aoun F; Diamand R; Al-Hajj Obeid W; Porpiglia F; Roumeguère T; De Nunzio C
Minerva Urol Nefrol; 2019 Feb; 71(1):1-8. PubMed ID: 30547907
[TBL] [Abstract][Full Text] [Related]
6. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives.
Bayne CE; Williams SB; Cooperberg MR; Gleave ME; Graefen M; Montorsi F; Novara G; Smaldone MC; Sooriakumaran P; Wiklund PN; Chapin BF
Eur Urol; 2016 May; 69(5):775-87. PubMed ID: 26003223
[TBL] [Abstract][Full Text] [Related]
7. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Heidenreich A; Pfister D
Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
[TBL] [Abstract][Full Text] [Related]
8. [Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study].
Heidenreich A; Pfister D; Brehmer B; Porres D
Urologe A; 2015 Jan; 54(1):14-21. PubMed ID: 25519996
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.
Becker JA; Berg KD; Røder MA; Brasso K; Iversen P
Scand J Urol; 2018 Feb; 52(1):1-7. PubMed ID: 28818014
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
11. Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.
Steuber T; Berg KD; Røder MA; Brasso K; Iversen P; Huland H; Tiebel A; Schlomm T; Haese A; Salomon G; Budäus L; Tilki D; Heinzer H; Graefen M; Mandel P
Eur Urol Focus; 2017 Dec; 3(6):646-649. PubMed ID: 28753877
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy for locally advanced and metastatic prostate cancer.
Veeratterapillay R; Goonewardene SS; Barclay J; Persad R; Bach C
Ann R Coll Surg Engl; 2017 Apr; 99(4):259-264. PubMed ID: 28349755
[TBL] [Abstract][Full Text] [Related]
13. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective Local Treatment of Metastatic Prostate Cancer (LoMP) Trial.
Poelaert F; Verbaeys C; Rappe B; Kimpe B; Billiet I; Plancke H; Decaestecker K; Fonteyne V; Buelens S; Lumen N
Urology; 2017 Aug; 106():146-152. PubMed ID: 28435034
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of cytoreductive prostatectomy in patients with metastatic disease.
Jaber Y; Reichard CA; Chapin BF
Transl Androl Urol; 2018 Sep; 7(Suppl 4):S505-S513. PubMed ID: 30363448
[TBL] [Abstract][Full Text] [Related]
16. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial.
Mandel PC; Huland H; Tiebel A; Haese A; Salomon G; Budäus L; Tilki D; Chun F; Heinzer H; Graefen M; Pantel K; Riethdorf S; Steuber T
Eur Urol Focus; 2021 Jan; 7(1):55-62. PubMed ID: 31178293
[TBL] [Abstract][Full Text] [Related]
17. The role of cytoreductive radical prostatectomy and lymph node dissection in bone-metastatic prostate cancer: A population-based study.
Zhai T; Ma J; Liu Y; Li H; Peng Y; Guo W; Jia J; Wu X; Jiang H; Tian J; Wang D
Cancer Med; 2023 Aug; 12(16):16697-16706. PubMed ID: 37366247
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer.
Preisser F; Nazzani S; Mazzone E; Marchioni M; Bandini M; Tian Z; Haese A; Saad F; Zorn K; Montorsi F; Shariat SF; Graefen M; Tilki D; Karakiewicz PI
Clin Genitourin Cancer; 2019 Oct; 17(5):e939-e945. PubMed ID: 31375352
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive prostatectomy: evidence in support of a new surgical paradigm (Review).
Faiena I; Singer EA; Pumill C; Kim IY
Int J Oncol; 2014 Dec; 45(6):2193-8. PubMed ID: 25340386
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer.
Preisser F; Mazzone E; Nazzani S; Bandini M; Tian Z; Marchioni M; Steuber T; Saad F; Montorsi F; Shariat SF; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol; 2018 Dec; 74(6):693-696. PubMed ID: 30037529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]